Author:
Keiser Philip H, ,Sension Michael G,DeJesus Edwin,Rodriguez Allan,Olliffe Jeffrey F,Williams Vanessa C,Wakeford John H,Snidow Jerry W,Shachoy-Clark Anne D,Fleming Julie W,Pakes Gary E,Hernandez Jaime E
Publisher
Springer Science and Business Media LLC
Reference45 articles.
1. Palella FJ, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, Aschman DJ, Holmberg SD: Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med. 1998, 338: 853-860. 10.1056/NEJM199803263381301.
2. Hogg RS, Yip B, Kully C, Craib KJ, O'Shaughnessy MV, Schechter MT, Montaner JS: Improved survival among HIV-infected patients after initiation of triple-drug antiretroviral regimens. CMAJ. 1999, 160: 659-665.
3. Jordan J, Carranza Rosenzweig J, Pathak D, Pilon T: Perceived influence of regimen characteristics on adherence. 5th International Congress on Drug Therapy in HIV Infection. Glasgow, United Kingdom. Abstract/Poster 121: October 22–26, 2000
4. Currier JS: Cardiovascular risk associated with HIV therapy. J Acquir Immune Defic Syndr. 2002, 31 (suppl 1): S16-S23.
5. Periard D, Telenti A, Sudre P, Cheseaux JJ, Halfon P, Reymond MJ, Marcovina SM, Glauser MP, Nicod P, Darioli R, Mooser V: Atherogenic dyslipidemia in HIV-infected individuals treated with protease inhibitors. The Swiss HIV Cohort Study. Circulation. 1999, 100: 700-705.
Cited by
36 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献